This concept will be interesting to explore further, given that Nuhn and his colleagues note that in localized treatment with IMDQnano, based on core-crosslinked block copolymers and combined with anti-PD-L1 checkpoint inhibition and Flt3L, a growth factor did show improved anti-tumor efficacy (Figure 3D) [76]. This evidence concerns the gene CD274 and neoplasm.